熱門資訊> 正文
NeuroMetrics报告第三季度业绩
2024-11-05 20:28
- NeuroMetrix press release (NASDAQ:NURO): Q3 Revenue of $0.6 million was lower by $0.6 million or 51% from Q3 2023. DPNCheck was the primary factor in the decline.
- Net loss was $1.5 million, or ($0.75) per share, versus $1.8 million, or ($1.66) per share, in Q3 2023.
More on NeuroMetrix
- NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript
- Financial information for NeuroMetrix
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。